Fetal vs Perinatal EVs as potential OA Therapeutics
Fetal vs Perinatal EVs as potential OA Therapeutics September 2nd, 2025, Vienna, Austria We are pleased to share a new publication
By Giulia Corso|2025-09-02T08:43:58+00:00September 2nd, 2025|collaboration, EV cell factories, mesenchymal stromal cells, publication, recent highlights EV, telomerized cells|
Fetal vs Perinatal EVs as potential OA Therapeutics September 2nd, 2025, Vienna, Austria We are pleased to share a new publication
By Giulia Corso|2025-04-08T09:37:08+00:00April 8th, 2025|conferences, EV cell factories, EVscale, Extracellular Vesicles, mesenchymal stromal cells|
Meet us at ISEV2025 April 8th, 2025, Vienna, Austria Visit us at booth B13 at the ISEV 2025 meeting in Vienna,
By Giulia Corso|2024-09-26T11:26:20+00:00September 26th, 2024|conferences, EV cell factories, EVscale, Extracellular Vesicles, mesenchymal stromal cells|
We participated to the ASEV and CzeSEV 2024 meeting in Vienna, Austria September 26th, 2024, Vienna, Austria We participated to the
By Giulia Corso|2024-09-26T11:28:45+00:00June 27th, 2024|cell line development, conferences, EV cell factories, extracellular vesicles, organ-on-a-chip|
Evercyte highlights immortalized cell technology at SelectBIO Rotterdam 2024 June 27th, 2024, Vienna, Austria We participated as technology spotlight speakers at
By Giulia Corso|2024-09-26T11:30:10+00:00November 22nd, 2023|cell line development, collaboration, EV cell factories, Extracellular Vesicles, mesenchymal stromal cells|
Evercyte Showcases Expertise in Japan’s Pharma Landscape November 22nd, 2023, Vienna, Austria We recently visited Summit Pharmaceuticals International to present our